GlaxoSmithKline Pharmaceuticals Limited (BSE: 500660)
Health Care · Pharmaceuticals · IN
Rs2,539.80
-8.46% today · -8.1% 1Y
GlaxoSmithKline Pharmaceuticals Limited (BSE: 500660) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $4.45B.
Over the last twelve months the share price has lost 8.1%, trading between 2.09K and 3.12K.
Tweenvest scores GlaxoSmithKline Pharmaceuticals Limited across four factors: quality 90/100, value 50/100, growth 53/100, dividend 63/100. Its strongest factor is quality.
500660 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.45B
- Revenue (TTM)
- $418.28M
- P/E
- 40.28
- EPS
- 63.05
- Dividend yield
- 2.24%
- Beta (5Y)
- 0.08
- 52-week high
- Rs3,121.10
- 52-week low
- Rs2,088.00
- Avg volume (3M)
- —
- Shares outstanding
- 169.41M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Hanmi Pharm. Co., Ltd.KOSE: A128940 | $4.54B | ₩480,500.00 | -5.04% |
| Sumitomo Pharma Co., Ltd.TSE: 4506 | $4.51B | ¥1,591.50 | -1.36% |
| Hikma Pharmaceuticals PLCLSE: HIK | $4.46B | £16.12 | +0.31% |
| Dong-E-E-Jiao Co., Ltd.SZSE: 000423 | $4.45B | CN¥46.68 | +0.56% |
| Ajanta Pharma LimitedNSEI: AJANTPHARM | $4.40B | Rs3,410.10 | -4.77% |
| Dottikon ES Holding AGSWX: DESN | $4.32B | CHF260.00 | +1.36% |
| Changchun High-Tech Industry (Group) Co., Ltd.SZSE: 000661 | $4.31B | CN¥71.90 | +3.86% |
| Apeloa Pharmaceutical Co.,LtdSZSE: 000739 | $4.27B | CN¥25.40 | -8.44% |
Figures last refreshed Oct 11, 2026.